Clinicomorphologic markers for predicting behavior and guiding therapy for brain tumors

Area of Science:

• Neuro-oncology
• Diagnostic Pathology

Background:

• Accurate brain tumor diagnosis is crucial for effective treatment planning.
• Morphologic markers can indicate tumor type, spread, and responsiveness to therapy.

Purpose of the Study:

• To highlight the importance of clinicomorphologic evaluation in brain tumor management.
• To emphasize the role of specific markers in guiding therapeutic strategies.

Main Methods:

• Review of clinical manifestations, imaging (CT, angiography), and operative findings.
• Cytologic examination of cerebrospinal fluid (CSF) for malignant cells.
• Correlation of morphologic features with treatment response.

Main Results:

• Primitive neuroectodermal tumor cells indicate CSF spread and radioresponsiveness.
• Metastatic neoplasms show markers like hemorrhage and meningeal involvement.
• CSF cytology aids in identifying malignant cells in nearly half of metastatic cases.
• Primitive neuroectodermal tumor cells in glioblastomas suggest CSF spread and radioresponsiveness.

Conclusions:

• Thorough clinicomorphologic evaluation is essential for effective brain tumor treatment.
• Identifying specific markers enables more aggressive and tailored therapeutic approaches.
• Advanced therapies can be optimized with precise diagnostic evaluations.